Hui Li

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 12

Top Topics

Metastatic Colorectal Cancer

Gold Nanoparticles

Brain Metastases

Top Venues

Cell death & disease

Molecular cancer therapeutics

Thoracic cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Yanjun Xu, Kaibo Ding, Zhongsheng Peng, Ling Ding, Hui Li, Yun Fan
Evaluating for correlations between metabolites in patients receiving immunotherapy for metastatic or recurrent NSCLC: an exploratory study based on two cohorts. Molecular cancer therapeutics (2024)
Yanjun Xu, Kaibo Ding, Zhongsheng Peng, Ling Ding, Hui Li, Yun Fan
Evaluating for Correlations between Specific Metabolites in Patients Receiving First-Line or Second-Line Immunotherapy for Metastatic or Recurrent NSCLC: An Exploratory Study Based on Two Cohorts. Molecular cancer therapeutics 23 (5) (2024)
Yanjun Xu, Kaibo Ding, Zhongsheng Peng, Ling Ding, Hui Li, Yun Fan
Evaluating for Correlations between Specific Metabolites in Patients Receiving First-Line or Second-Line Immunotherapy for Metastatic or Recurrent NSCLC: An Exploratory Study Based on Two Cohorts. Molecular cancer therapeutics 23 (5) (2024)
Yanjun Xu, Kaibo Ding, Zhongsheng Peng, Ling Ding, Hui Li, Yun Fan
Evaluating for Correlations between Specific Metabolites in Patients Receiving First-Line or Second-Line Immunotherapy for Metastatic or Recurrent NSCLC: An Exploratory Study Based on Two Cohorts. Molecular cancer therapeutics 23 (5) (2024)
Hui Li, Yong-Chang Zhang, Yanjun Xu, Zhiyu Huang, Guoping Cheng, Ming-Ying Xie, Zi-Chao Zhou, Yangyang Yu, Wenjing Xi, Yun Fan
Tumor immune microenvironment and immunotherapy efficacy in BRAF mutation non-small-cell lung cancer. Cell death & disease 13 (12) (2022)
Hui Li, Yong-Chang Zhang, Yanjun Xu, Zhiyu Huang, Guoping Cheng, Ming-Ying Xie, Zi-Chao Zhou, Yangyang Yu, Wenjing Xi, Yun Fan
Tumor immune microenvironment and immunotherapy efficacy in BRAF mutation non-small-cell lung cancer. Cell death & disease 13 (12) (2022)
Hui Li, Yong-Chang Zhang, Yanjun Xu, Zhiyu Huang, Guoping Cheng, Ming-Ying Xie, Zi-Chao Zhou, Yangyang Yu, Wenjing Xi, Yun Fan
Tumor immune microenvironment and immunotherapy efficacy in BRAF mutation non-small-cell lung cancer. Cell death & disease 13 (12) (2022)
Hui Li, Yong-Chang Zhang, Yanjun Xu, Zhiyu Huang, Guoping Cheng, Ming-Ying Xie, Zi-Chao Zhou, Yangyang Yu, Wenjing Xi, Yun Fan
Tumor immune microenvironment and immunotherapy efficacy in BRAF mutation non-small-cell lung cancer. Cell death & disease 13 (12) (2022)
Hui Li, Yong-Chang Zhang, Yanjun Xu, Zhiyu Huang, Guoping Cheng, Ming-Ying Xie, Zi-Chao Zhou, Yangyang Yu, Wenjing Xi, Yun Fan
Tumor immune microenvironment and immunotherapy efficacy in BRAF mutation non-small-cell lung cancer. Cell death & disease 13 (12) (2022)
Hui Li, Ning Wang, Yu Jiang, Haofei Wang, Zengfeng Xin, Huazhang An, Hao Pan, Wangqian Ma, Ting Zhang, Xiaojian Wang, Wenlong Lin
E3 ubiquitin ligase NEDD4L negatively regulates inflammation by promoting ubiquitination of MEKK2. EMBO reports 23 (11) (2022)
Jia-Min Sheng, Hui Li, Xiaoqing Yu, Sizhe Yu, Kai-Yan Chen, Guoqiang Pan, Ming-Ying Xie, Na Li, Zi-Chao Zhou, Yun Fan
Efficacy of PD-1/PD-L1 inhibitors in patients with non-small cell lung cancer and brain metastases: A real-world retrospective study in China. Thoracic cancer 12 (22) (2021)
Lei Gong, Ronghui He, Yanjun Xu, Taobo Luo, Kaixiu Jin, Wuzhou Yuan, Zengguang Zheng, Lanxuan Liu, Zebin Liang, Ao Li, Zhiguo Zheng, Hui Li
Neoantigen load as a prognostic and predictive marker for stage II/III non-small cell lung cancer in Chinese patients. Thoracic cancer 12 (15) (2021)